FOUSE JACQUALYN A 4
4 · AGIOS PHARMACEUTICALS, INC. · Filed Jun 17, 2024
Insider Transaction Report
Form 4
FOUSE JACQUALYN A
Director
Transactions
- Exercise/Conversion
Common stock
2024-06-13+3,388→ 140,784 total - Exercise/Conversion
Restricted stock units
2024-06-13−3,388→ 0 total→ Common stock (3,388 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
- [F2]The restricted stock units were granted on June 13, 2023. The shares underlying the stock units vest in full on June 13, 2024. Vested shares will be delivered to the reporting person within three business days after such shares become vested.